SE9004039L - 3-(n-metyl-n-alkyl)-amino-2-metoximetylen-propan-1-ol-derivat, ett framstaellningsfoerfarande foer desamma samt terapeutiska kompositioner innehaallande dem - Google Patents
3-(n-metyl-n-alkyl)-amino-2-metoximetylen-propan-1-ol-derivat, ett framstaellningsfoerfarande foer desamma samt terapeutiska kompositioner innehaallande demInfo
- Publication number
- SE9004039L SE9004039L SE9004039A SE9004039A SE9004039L SE 9004039 L SE9004039 L SE 9004039L SE 9004039 A SE9004039 A SE 9004039A SE 9004039 A SE9004039 A SE 9004039A SE 9004039 L SE9004039 L SE 9004039L
- Authority
- SE
- Sweden
- Prior art keywords
- alkyl
- propan
- amino
- methyl
- compositions containing
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical group N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229910021529 ammonia Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/10—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
- C07D213/20—Quaternary compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898928580A GB8928580D0 (en) | 1989-12-19 | 1989-12-19 | 3-(n-methyl-n-alkylamino)-methoxymethyl-propanol phosphocholine derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE9004039D0 SE9004039D0 (sv) | 1990-12-18 |
| SE9004039L true SE9004039L (sv) | 1991-06-20 |
| SE469383B SE469383B (sv) | 1993-06-28 |
Family
ID=10668132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9004039A SE469383B (sv) | 1989-12-19 | 1990-12-18 | 3-(n-metyl-n-alkyl)-amino-2-metoximetylen-propan-1-ol- derivat, ett framstaellningsfoerfarande foer desamma samt terapeutiska kompositioner innehaallande dem |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US5118674A (sv) |
| JP (1) | JPH04208256A (sv) |
| KR (1) | KR910011759A (sv) |
| AR (1) | AR246742A1 (sv) |
| AT (1) | AT400333B (sv) |
| AU (1) | AU630056B2 (sv) |
| BE (1) | BE1004089A3 (sv) |
| CA (1) | CA2032224C (sv) |
| CH (1) | CH681624A5 (sv) |
| DE (1) | DE4040685A1 (sv) |
| DK (1) | DK171298B1 (sv) |
| DZ (1) | DZ1471A1 (sv) |
| ES (1) | ES2023607A6 (sv) |
| FI (1) | FI906162A (sv) |
| FR (2) | FR2656797B1 (sv) |
| GB (2) | GB8928580D0 (sv) |
| GR (1) | GR1000893B (sv) |
| HK (1) | HK118093A (sv) |
| IE (1) | IE65888B1 (sv) |
| IN (1) | IN173969B (sv) |
| IT (1) | IT1243412B (sv) |
| LU (1) | LU87853A1 (sv) |
| MA (1) | MA22013A1 (sv) |
| MY (1) | MY104781A (sv) |
| NL (1) | NL9002582A (sv) |
| NO (1) | NO177146C (sv) |
| NZ (1) | NZ236213A (sv) |
| OA (1) | OA09475A (sv) |
| PT (1) | PT96265B (sv) |
| SE (1) | SE469383B (sv) |
| TN (1) | TNSN90152A1 (sv) |
| ZA (1) | ZA909663B (sv) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0717631B1 (en) | 1993-09-09 | 2003-07-09 | Lorus Therapeutics Inc. | Immunomodulating compositions from bile |
| US6551623B1 (en) | 1993-09-09 | 2003-04-22 | Lorus Therapeutics Inc. | Immunomodulating compositions from bile |
| AU711294B2 (en) | 1995-03-16 | 1999-10-07 | Erin Mills Biotech Inc. | Immunomodulating compositions from bile for the treatment of immune system disorders |
| US20040101569A1 (en) * | 1996-05-16 | 2004-05-27 | Lorus Therapeutics Inc. | Immunomodulating compositions from bile |
| DE19711758C2 (de) * | 1997-03-21 | 2003-06-18 | Degussa | Verfahren zur Herstellung von 1,3-Dioxanverbindungen |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2732263A1 (de) * | 1977-07-16 | 1979-02-01 | Schuler Gmbh L | Vorrichtung zum herstellen einer sicke am umfang eines hohlzylinders |
| DE2820893C2 (de) * | 1978-05-12 | 1986-02-20 | A. Nattermann & Cie GmbH, 5000 Köln | Strukturanaloga von natürlichen Phospholipiden und Verfahren zur Herstellung dieser Verbindungen |
| US4737518A (en) * | 1984-04-03 | 1988-04-12 | Takeda Chemical Industries, Ltd. | Lipid derivatives, their production and use |
| WO1989007099A1 (en) * | 1988-02-05 | 1989-08-10 | Schering Corporation | 2,2-disubstituted glycerol and glycerol-like compounds, compositions and methods of use |
| JP2534893B2 (ja) * | 1988-06-24 | 1996-09-18 | 日本ケミファ株式会社 | 新規なグリセリン誘導体およびその誘導体を含有する血小板凝集抑制剤 |
| DE3906952A1 (de) * | 1989-03-04 | 1990-09-06 | Boehringer Mannheim Gmbh | (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel |
| GR1000688B (el) * | 1989-12-22 | 1992-10-08 | Sod Conseils Rech Applic | Μεθοδος παρασκευης παραγωγων γλυκερινης. |
-
1989
- 1989-12-19 GB GB898928580A patent/GB8928580D0/en active Pending
-
1990
- 1990-11-16 GR GR900100812A patent/GR1000893B/el unknown
- 1990-11-16 IN IN1132DE1990 patent/IN173969B/en unknown
- 1990-11-26 CH CH3736/90A patent/CH681624A5/fr not_active IP Right Cessation
- 1990-11-26 NZ NZ236213A patent/NZ236213A/xx unknown
- 1990-11-27 NL NL9002582A patent/NL9002582A/nl not_active Application Discontinuation
- 1990-11-27 US US07/618,700 patent/US5118674A/en not_active Expired - Fee Related
- 1990-11-28 ES ES9003036A patent/ES2023607A6/es not_active Expired - Fee Related
- 1990-11-30 ZA ZA909663A patent/ZA909663B/xx unknown
- 1990-11-30 MY MYPI90002111A patent/MY104781A/en unknown
- 1990-12-05 AR AR90318536A patent/AR246742A1/es active
- 1990-12-06 LU LU87853A patent/LU87853A1/fr unknown
- 1990-12-10 MA MA22288A patent/MA22013A1/fr unknown
- 1990-12-12 NO NO905373A patent/NO177146C/no unknown
- 1990-12-13 CA CA002032224A patent/CA2032224C/en not_active Expired - Fee Related
- 1990-12-14 FI FI906162A patent/FI906162A/fi not_active IP Right Cessation
- 1990-12-14 BE BE9001201A patent/BE1004089A3/fr not_active IP Right Cessation
- 1990-12-16 DZ DZ900227A patent/DZ1471A1/fr active
- 1990-12-18 AU AU68142/90A patent/AU630056B2/en not_active Ceased
- 1990-12-18 KR KR1019900020921A patent/KR910011759A/ko not_active Application Discontinuation
- 1990-12-18 IE IE456790A patent/IE65888B1/en not_active IP Right Cessation
- 1990-12-18 DK DK299590A patent/DK171298B1/da not_active IP Right Cessation
- 1990-12-18 SE SE9004039A patent/SE469383B/sv unknown
- 1990-12-18 GB GB9027421A patent/GB2239239B/en not_active Expired - Fee Related
- 1990-12-19 FR FR909015900A patent/FR2656797B1/fr not_active Expired - Fee Related
- 1990-12-19 JP JP2417907A patent/JPH04208256A/ja active Pending
- 1990-12-19 PT PT96265A patent/PT96265B/pt not_active IP Right Cessation
- 1990-12-19 DE DE4040685A patent/DE4040685A1/de not_active Ceased
- 1990-12-19 AT AT0259590A patent/AT400333B/de not_active IP Right Cessation
- 1990-12-19 IT IT02243890A patent/IT1243412B/it active IP Right Grant
- 1990-12-19 TN TNTNSN90152A patent/TNSN90152A1/fr unknown
- 1990-12-19 FR FR909015901A patent/FR2656307B1/fr not_active Expired - Fee Related
- 1990-12-19 OA OA59924A patent/OA09475A/xx unknown
-
1993
- 1993-11-04 HK HK1180/93A patent/HK118093A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL194914B (nl) | 4H-1-benzopyran-4-onderivaat of zout daarvan, en farmaceutisch preparaat dat dit als actieve stof bevat. | |
| FR2382441A1 (fr) | Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides utiles en tant que medicaments et procedes pour leur preparation | |
| PT850926E (pt) | Derivados da difluoroprostaglandina e sua utilizacao | |
| DE3362241D1 (de) | Antifungal triazolyl propanol derivatives | |
| ES2147749T3 (es) | Procedimiento para la preparacion de derivados de ciano-metoxiiminometilo. | |
| ES2033062T3 (es) | Un procedimiento de preparacion de derivados n-imidazolil y n-imidazolilmetil. | |
| GB2285444A (en) | Arylsulfonamide derivative and pharmaceutical composition containing the same | |
| MX9202975A (es) | Nuevos compuestos biciclicos y sus sales farmaceuticamente aceptables y procedimiento para su preparacion. | |
| SE9004039D0 (sv) | 3-(n-metyl-n-alkyl)-amino-2-metoximetylen-propan-1-ol-derivat, ett framstaellningsfoerfarande foer desamma samt terapeutiska kompositioner innehaallande dem | |
| SE9003973D0 (sv) | Glycerol, ett framstaellningsfoerfarande foer desamma samt terapeutiska kompositioner innehaallande dem | |
| NO951135D0 (no) | Syntese av N-acetyl-neuraminsyrederivater | |
| ES2118650T3 (es) | Derivados de la quinolina-4-carbonilguanidina, procedimiento para la preparacion de los mismos y preparaciones farmaceuticas que contienen los compuestos. | |
| BR9502079A (pt) | Composto,formulação farmaceutica e processo para preparar um composto | |
| DK0429370T3 (da) | Hiditl ukendte thiophenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| ES2082882T3 (es) | Procedimiento para la fabricacion de derivados de acidos-3-amino-2-(het)aroil-acrilicos. | |
| GR3020190T3 (en) | Diclofenac choline salt, a method for the preparation thereof and pharmaceutical compositions containing it | |
| GR3020509T3 (en) | Alpha-methylene-2-vinyl-benzeneacetic acid derivatives, process for their preparation and their use as pesticides | |
| HU903092D0 (en) | Process for the preparation of buten-carboxylic acid derivatives and pharmaceutical compositions containing such compounds | |
| ES516158A0 (es) | Procedimiento de preparacion de nuevos derivados del adamantano. | |
| HU911520D0 (en) | Process for producing spiro-dibenzo-suberane derivatives | |
| SE8801945D0 (sv) | New 5-methoxy alkyl ammonium tetrahydrofurans and tetrahydrothiophenes | |
| FR2357527A1 (fr) | Nouveau procede de synthese du chlorhydrate de derives particuliers de catecholamine | |
| SE8801964D0 (sv) | New 5-(omega-ammonio acyloxy methylene) tetrahydrofurans and tetrahydrothiophenes | |
| EP0139590A3 (en) | 4-alkyl-2-hydroxy-3-methyl-2-phenyl-morpholine derivatives, process for their preparation and their therapeutical use | |
| ES2082815T3 (es) | Procedimiento para la fabricacion de productos intermedios y para la sintesis de n-(2-hidroxietil)-2-hidroximetil-3,4,5-trihidroxipiperidinas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 9004039-5 Format of ref document f/p: F |